Thornburg Investment Management Inc Astrazeneca PLC Transaction History

Thornburg Investment Management Inc

$7.17 Billion
Q3 2024

A detailed history of Thornburg Investment Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Thornburg Investment Management Inc holds 486,026 shares of AZN stock, worth $32.7 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

486,026

Previous 491,469 1.11%

Holding current value

$32.7 Million

Previous $38.3 Million 1.19%

% of portfolio

0.53%

Previous 0.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $417,314 - $476,915	-5,443 Reduced 1.11%	486,026 $37.9 Million
Q2 2024 Aug 07, 2024	SELL	$66.81 - $80.83 $651,931 - $788,739	-9,758 Reduced 1.95%	491,469 $38.3 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $466,574 - $531,862	-7,645 Reduced 1.5%	501,227 $34 Million
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $3.91 Million - $4.38 Million	-63,208 Reduced 11.05%	508,872 $34.3 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $536,633 - $593,317	-8,275 Reduced 1.43%	572,080 $38.7 Million
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $7.44 Million - $8.07 Million	-106,403 Reduced 15.49%	580,355 $41.5 Million
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $2.76 Million - $3.13 Million	-43,674 Reduced 5.98%	686,758 $47.7 Million
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $6.96 Million - $9.05 Million	-128,439 Reduced 14.95%	730,432 $49.7 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2.84 Million - $7.27 Million	53,521 Added 6.65%	858,871 $47.1 Million
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $9.26 Million - $11.1 Million	-156,280 Reduced 16.25%	805,350 $53.2 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $5.53 Million - $6.66 Million	-99,264 Reduced 9.36%	961,630 $63.8 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $5.15 Million - $6.09 Million	95,371 Added 9.88%	1,060,894 $61.8 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $255,409 - $279,451	4,597 Added 0.48%	965,523 $58 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $4.1 Million - $5.1 Million	84,732 Added 9.67%	960,926 $57.6 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $5.76 Million - $6.65 Million	122,200 Added 16.21%	876,194 $43.6 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $207,811 - $248,499	-4,283 Reduced 0.56%	753,994 $37.7 Million
Q3 2020 Nov 05, 2020	SELL	$53.07 - $61.1 $205,115 - $236,151	-3,865 Reduced 0.51%	758,277 $41.6 Million
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $643,827 - $826,220	-14,938 Reduced 1.92%	762,142 $40.3 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $523,542 - $711,125	13,854 Added 1.82%	777,080 $34.7 Million
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $1.11 Million - $1.32 Million	-26,148 Reduced 3.31%	763,226 $38.1 Million
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $413,597 - $468,750	-10,309 Reduced 1.29%	789,374 $35.2 Million
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $3.45 Million - $3.86 Million	92,621 Added 13.1%	799,683 $33 Million
Q1 2019 May 07, 2019	BUY	$35.49 - $43.02 $1.87 Million - $2.27 Million	52,782 Added 8.07%	707,062 $28.6 Million
Q4 2018 Feb 06, 2019	SELL	$36.86 - $41.49 $254,112 - $286,032	-6,894 Reduced 1.04%	654,280 $24.9 Million
Q3 2018 Nov 02, 2018	BUY	$34.76 - $39.72 $2.58 Million - $2.95 Million	74,166 Added 12.63%	661,174 $26.2 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $5.31 Million - $5.7 Million	153,785 Added 35.5%	587,008 $20.6 Million
Q1 2018 May 07, 2018	BUY	$32.97 - $36.63 $14.3 Million - $15.9 Million	433,223 New	433,223 $15.2 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.

Account

Thornburg Investment Management Inc Astrazeneca PLC Transaction History